Equine metabolic syndrome (EMS) is a cluster of metabolic and clinical features whose consistent core is insulin dysregulation, and whose main consequence is laminitis. It is a first-order endocrine laminitis topic on the NAVLE and the key contrast is with PPID and hypothyroidism, which are tested next to it. This guide follows MSD (review August 2025) and the Equine Endocrinology Group (EEG) EMS and insulin dysregulation recommendations.
Key facts
Equine Metabolic syndrome at a glance- Species and system: horses, ponies and donkeys; multisystemic (endocrine, hoof, reproductive).
- Core feature: insulin dysregulation, meaning resting hyperinsulinemia, postprandial hyperinsulinemia or insulin resistance.
- Classic horse: overweight with a cresty neck and regional fat (neck, tailhead, behind the shoulder), recurring laminitis; a lean phenotype also exists.
- Laminitis: hyperinsulinemia-associated laminitis accounts for about 90 percent of laminitis in the general equine population (MSD).
- Diagnosis: document insulin dysregulation: basal insulin, oral sugar test, insulin tolerance test. Glucose is not diagnostic.
- Management: diet and hoof care first; drugs only extralabel and after diet.
What's inside
11 sections in the full guide- Key facts
- How the NAVLE tests this
- Cause and pathophysiology
- Clinical signs
- Diagnosis
- Differential diagnoses
- Treatment and management
- Prognosis and prevention
- Quick review
- Test yourself
- References
The full guide also has 4 tables, 3 self-test questions and 5 references, available to NAVLE members.
Read the full study guide
The full guide is part of every NAVLE plan, with diagnosis and treatment tables, figures, a quick review and self-test questions. Start a free trial to try the question bank, or log in if you are already a member.